Finding Immune Nascent Type 1 Diabetes (FIND T1D)
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 3,800
- 试验地点
- 1
研究概览
简要总结
The goal of this clinical trial is to understand how many individuals who previously participated in the Indiana Biobank will return a type 1 diabetes home screening kit based upon different methods of recruitment communication. The main question it aims to answer is:
What form of recruitment communication is most effective for completing a type 1diabetes home screening kit?
Researchers will compare two types of recruitment contact: email and mail based communication (low-touch) versus phone contact and follow-up by a research team member (high-touch).
Participants will be contacted either via email/mail or by phone and asked if they want to complete a type 1 diabetes home screening kit.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Screening
- 盲法
- None
入排标准
- 年龄范围
- 1 Year 至 99 Years(Child, Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Participant must be in Indiana Biobank
- •Participant must be able to provide consent
- •Ages 1-99 including pregnant women
排除标准
- •Refusal to sign informed consent for home screening is exclusionary for the home screening portion of the study
- •While other medical conditions are allowable prior diabetes diagnosis is exclusionary for home autoantibody screening
研究者
Emily K. Sims
Associate Professor of Pediatrics
Indiana University
